This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Acrobiosystems, Inc., Single Cell Technology, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 6 Years Active: 2024
Title: Innovations of Xiaojuan Shi in Antibody Development
Introduction
Xiaojuan Shi is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on the B-Cell Maturation Antigen (BCMA), which plays a crucial role in various medical applications.
Latest Patents
Xiaojuan Shi holds a patent for Anti-BCMA antibodies. This patent provides antibodies that recognize the B-Cell Maturation Antigen (BCMA) and outlines methods of use for these antibodies. His innovative approach has the potential to impact therapeutic strategies in treating diseases related to B-cells.
Career Highlights
Throughout his career, Xiaojuan Shi has worked with prominent companies in the biotechnology sector. He has been associated with Single Cell Technology, Inc. and Acrobiosystems, Inc. These experiences have allowed him to refine his skills and contribute to groundbreaking research in antibody development.
Collaborations
Xiaojuan Shi has collaborated with talented individuals in his field, including Leyan Tang and Allison Schulkins. Their combined expertise has fostered an environment of innovation and advancement in antibody research.
Conclusion
Xiaojuan Shi's contributions to the development of Anti-BCMA antibodies highlight his role as a significant inventor in biotechnology. His work not only showcases his innovative spirit but also has the potential to lead to advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile